StockWatch
·
HomeLiveReports
Pharmaceuticals
Board Meeting21 Oct 2026, 05:10 pm

Gland Pharma Board Meeting on Nov 6 to Approve Q2 FY27 Results

AI Summary

Gland Pharma Limited has announced that its Board of Directors will convene on Friday, November 6, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The trading window, previously closed on October 1, 2026, will reopen on November 9, 2026. An Investor/Analyst call is scheduled for the same day, November 6, 2026, at 18:30 IST.

Key Highlights

  • Board meeting scheduled for November 6, 2026.
  • To approve Unaudited Financial Results for Q2 FY27.
  • Trading window reopens on November 9, 2026.
  • Earnings call scheduled for November 6, 2026.
View BSE Filing
GLAND
Pharmaceuticals
Gland Pharma Ltd

Price Impact

More from GLAND

USFDA1d ago, 4:23 pm

Gland Pharma: USFDA Inspection Concluded with 4 Observations

Management Change1 Oct, 3:55 pm

Gland Pharma: Director Resigns, New Director Appointed; Invests $21M in US Subsidiary

Investment1 Oct, 3:53 pm

Gland Pharma Invests $21M in US Subsidiary, Novelstar Pharma

More in Board Meeting

SUMEETINDS43m ago

Sumeet Industries Board Meeting on Oct 31 to Approve Un-Audited Financials

ELECTHERM43m ago

Electrotherm Board Meeting on Nov 4 to Approve Q2 FY27 Results

SHIVKAMAL44m ago

Shivkamal Impex Board Meeting on Oct 31 for Unaudited Results